Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramlintide Infusion in Type 1 Diabetes
NCT00502138Phase 4Completed
- Sponsor
- University Diabetes & Endocrine Consultants
- Start
- Jul 2007
- Primary completion
- Jan 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pramlintide in type 1 diabetes mellitus (T1D), sponsored by University Diabetes & Endocrine Consultants. Primary endpoint: Fasting and postprandial pramlintide pharmacokinetics at 4 months. Started Jul 2007; status: completed.
02
Drugs
pramlintide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00502138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00502138.